Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer-Reference-Cited by-同舟云学术

Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer

Published:2013-10 Issue:1 Volume:131 Page:169-173
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Anwer Khursheed,Kelly F. Joseph,Chu Christina,Fewell Jason G.,Lewis Danny,Alvarez Ronald D.

Funder

FDA Office of Orphan Product Development

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Latest research and treatment of advanced-stage epithelial ovarian cancer;Coleman;Nat Rev Clin Oncol,2013

2. Novel therapies for recurrent ovarian cancer management;Bhoola;Expert Rev Anticancer Ther,2004

3. Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature;Whitworth;Expert Opin Biol Ther,2011

4. Rumpold H, Reimer D, et al. High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer;Wolf;Gynecol Oncol,2010

5. IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumor microenvironments;Simpson-Abelson;Clin Immunol,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Lipids: Exploring Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era;Advanced Materials;2024-06-19

2. Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity;Discover Oncology;2024-05-16

3. Musculoskeletal Organs‐on‐Chips: An Emerging Platform for Studying the Nanotechnology–Biology Interface;Advanced Materials;2024-03-28

4. Modification of the tumor microenvironment enhances immunity with plasmid gene therapy;Cancer Gene Therapy;2024-02-09

5. Polyethylenimine (PEI) in gene therapy: Current status and clinical applications;Journal of Controlled Release;2023-10